Esperion Therapeutics, Inc.
- ESPR
- NASDAQ
- Biotechnology
- Cardiovascular Drugs (LDL Cholesterol)
$3.18
Quote Jul 13, 2026, 08:00 PM UTC
+0.95%over the last month
Max drawdown −0.6%From 1-month high −0.3%3 months +43.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$799.3M
Approximate share count
Next earnings
—
Data unavailable
Analyst target
$3.19
+0.3% from here
Floor
$3.14
1.1% below price
Where the price sits
25 analysts
Analyst range, low to high
$3.16$3.28
- Price $3.18
- Resistance $3.20
- Consensus $3.19
The price is just above its floor and right under resistance. Analysts' average target sits about 0% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ESPRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q1 2026 revenue $80.1M
- Product$43.4M54.2%
- Collaboration Revenue$36.7M45.8%
Industry
Biotechnology
Employees
294